Pfizer elects CEO Ian Read as Chairman of the Board
12 December 2011
Pfizer Inc. has announced that its Board of Directors has elected Ian Read, as Chairman of the Board and CEO, effective immediately...
News
The latest news from the pharmaceutical industry. If you have a piece of news that you would like us to cover, please contact Pippa McCartney on +44(0) 1959 563311 or email us.
Abbott and Reata Pharmaceuticals announce agreement to develop and commercialize next-generation AIMs
12 December 2011
Agreement calls for 50/50 global profit share for multiple new molecules...
Katherine Baicker elected to Lilly Board of Directors
12 December 2011
Board of Directors of Eli Lilly and Company has elected Katherine Baicker, Ph.D. as a new member, effective December 12, 2011...
ICON acquires BeijingWits Medical Consulting Ltd
12 December 2011
ICON plc, has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting Ltd., a leading CRO in China...
University College Dublin and Elan announce initiative to create leadership in biotechnology
12 December 2011
€3m grant to combine business & science disciplines at University College Dublin...
B&W Tek announces PolymerIQTM for quantification of polymers in partnership with Gnosys Global Ltd
12 December 2011
B&W Tek, Inc., announced its newest strategic partnership with Gnosys Global, Ltd...
Merck announces results of ZOLINZA® (vorinostat) Phase III and IIb Trials for investigational use for multiple myeloma at American Society of Hematology Annual Meeting
12 December 2011
ZOLINZA in combination with Bortezomib achieved primary endpoint of improved progression-free survival in patients with relapsed and/or refractory multiple myeloma in Phase III trial...
Two Novartis Phase III studies show twice as many Ph+ CML patients achieve deeper levels of response with Tasigna® compared to Glivec®
12 December 2011
Phase III clinical trial data presented...
Lilly oncology reveals findings from study of JAK2 inhibitor for blood cancers at ASH meeting
12 December 2011
Data from an oncology pipeline molecule announced at the ASH meeting...
Patient entry completed for Phase III trial programme in Hepatitis C
9 December 2011
The final patient has been randomised to treatment in the large-scale Phase III clinical trial programme for BI 201335...
AstraZeneca to acquire generics company to broaden patient access to medicines in China
8 December 2011
AstraZeneca to acquire Guangdong BeiKang Pharmaceutical Company Ltd...
PAT supplement
This free to view PAT supplement is sponsored by Sartorius, Extrel, ABB, Bruker Optics and FOSS NIRSystems:
Company directory
ABB Analytical Measurements | Almac | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Daltonik GmbH | CAMO Software AS | CI Precision | Cisbio Bioassays | Colder Products Company | Expo Technologies, LLC. | Freeman Technology | GE Analytical Instruments | HACH LANGE GMBH | HORIBA Scientific | Hudson Robotics, Inc. | Natoli Engineering Company, Inc. | Peter Huber Kältemaschinenbau GmbH | Randox Pharma Services | Rapid Micro Biosystems | Smithers Viscient | Synbiosis | Syngene | Watson-Marlow Pumps Group |
Login to access exclusive content